Intra-day tips from Geojit BNP Paribas; Buy HDFC Bank, Kalindee Rail

Here are a few intra-day trading strategies from Geojit BNP Paribas for trade today:

HDFC BANK (Rs 1,062.40)

Support at Rs 1,058 below Rs 1052. Resistance is at Rs 1,068 above Rs 1,079. (Buy for intraday with a stoploss below Rs 1,052)

[MACD BUY + ABV 200 DMA + VOLUME BUILDUP]

KALINDEE RAIL NIRMAN (ENGINEERS) (Rs 155.40)

Support at Rs 153 below Rs 151.10. Resistance is at Rs 158.90 above Rs 164. (Buy for intraday with a stoploss below Rs 151.10)

[ABV PREVIOUS CLOSE + ABV MOVING AVERAGES + MACD BUY]

TRIGYN TECHNOLOGIES (Rs 98.85)

Support at Rs 96.25 below Rs 94.70. Resistance is at Rs 103.30 above Rs 107. (Buy for intraday with a stoploss below Rs 94.70)
 

[MACD & STOCHASTICS BUY + VOLUME JUMP + ABV MOVING AVERAGES]

JAGSONPAL PHARMACEUTICALS (Rs 60.15)

Support at Rs 58.50 below Rs 57.25. Resistance is at Rs 63.25 above Rs 66 (Buy for intraday with a stoploss below Rs 57.25)

[STOCHASTICS BUY+ VOLUME JUMP+ ABV MOVING AVERAGES + NEW HIGH]

ONWARD TECHNOLOGIES (Rs 117.45)

Support at Rs 115 below Rs 113. Resistance is at Rs 121.75 above Rs 124. (Buy for intraday with a stoploss below Rs 113)

[OVERSOLD + STOCHASTICS BUY + ABV MOVING AVERAGES + VOLUME JUMP

Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.